SAM
AGN

Symphony Asset Management’s Allergan Inc AGN Stock Holding History

Symphony Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,493
Closed -$1.59M – 529
2014
Q4 		$1.59M Buy
7,493
+73
+1% +$14.5K 0.2% 121
2014
Q3 		$1.32M Sell
7,420
-3,292
-31% -$547K 0.14% 147
2014
Q2 		$1.81M Sell
10,712
-23,708
-69% -$3.69M 0.19% 139
2014
Q1 		$4.27M Sell
34,420
-701
-2% -$85.4K 0.41% 63
2013
Q4 		$3.9M Buy
35,121
+30,714
+697% +$2.93M 0.29% 65
2013
Q3 		$399K Sell
4,407
-740
-14% -$66.4K 0.04% 329
2013
Q2 		$433K Buy
+5,147
New +$534K 0.04% 315

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Symphony Asset Management's AGN Position: Q1 2015 in Review

Symphony Asset Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 7,493 shares — an estimated $1.59M sold.

Symphony Asset Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.27M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Symphony Asset Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Symphony Asset Management sold 7,493 Allergan Inc shares in Q1 2015, an estimated $1.59M.
  • Symphony Asset Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Symphony Asset Management's Allergan Inc position peaked at $4.27M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Symphony Asset Management's 13F filing for Q1 2015, filed 13 May 2015.